Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Alopecia areata patients may have higher T3 and cortisol levels, suggesting a hormonal link.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

Ritlecitinib is an effective new treatment for Alopecia Areata.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Hashimoto’s thyroiditis is more common in girls, often after puberty, and can cause neck swelling, fatigue, and hair loss.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Eyelash loss can be a sign of thyroid problems.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

TAK-279 effectively reduces psoriasis symptoms and is safe.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.